X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Bioengineering-Basel

期刊標題檢索 BIOENGINEERING- 最新評論: When I submitted my paper, I did not choose a special issue. However,... (2024-03-12)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Bioengineering-Basel]您好,您是該頁面的第 13679 位訪客。

期刊簡介
期刊名稱Bioengineering-Basel Bioengineering-Basel

(According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is )
LetPub Score
6.1
50 ratings
Rate

Reputation
7.0

Influence
5.2

Speed
7.2

期刊簡稱BIOENGINEERING-BASEL
ISSN2306-5354
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.000.6270.896
Subject fieldQuartilesRankPercentile
Category: Chemical Engineering
Subcategory: Bioengineering
Q3104 / 162

自引率 (2023-2024)10.50%自引率趨勢
掲載範囲
官方網站https://www.mdpi.com/journal/bioengineering
在線稿件提交
開放訪問Yes
出版商Multidisciplinary Digital Publishing Institute (MDPI)
主題領域ENGINEERING, BIOMEDICAL
出版國/地區Switzerland
發行頻率
創刊年0
每年文章數1410每年文章數趨勢
黃金OA百分比99.88%
OA Related Info
APC: Yes( CHF2700; )
APC waiver:No
Other charges: No
Keywords: bioelectronics、bionics、biosystems engineering、biomolecular engineering、biomedical engineering、biochemical engineering
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENGINEERING, BIOMEDICALSCIEQ244/122
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2306-5354%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 6 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Bioengineering-Basel】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640704
    BIOMATERIALS569630
    BIOMEDICINE & PHARMACOTHERAPY498327
    Frontiers in Pharmacology486598
    Journal of Materials Chemistry B476055
    JOURNAL OF ETHNOPHARMACOLOGY475801
    Frontiers in Immunology457847
    COLLOIDS AND SURFACES B-BIOINTERFACES419210
    COMPUTERS IN BIOLOGY AND MEDICINE416252
    Frontiers in Oncology413355
  •  

    Bioengineering-Basel Bioengineering-Basel
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Bioengineering-Basel] 的評論撰寫評論
作者: shhfu9jdh


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-12 14:59:48 評論於
When I submitted my paper, I did not choose a special issue. However, an editor emailed me recommending to transfer to a special issue that fits the theme better, and I agreed. The special issue expands the scope of the journal, but does not affect the review efficiency or publication and indexing after acceptance
(0) 讚! | shhfu9jdh

作者: 西城


領域: 计算机科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-06 10:33:52 評論於
Submitted on 3/4, but must select a special issue during the submission process, can't submit to his core journal
(0) 讚! | 西城

作者: 西城


領域: 计算机科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-06 10:33:02 評論於
Does this journal have to be assigned to his special issue?
(0) 讚! | 西城

作者: shhfu9jdh


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-12-21 22:39:54 評論於
I thought that there would be minor revisions after the first review, but the reviewers provided a lot of suggestions, some of which were difficult to address. It was not until after major revisions that the paper was finally accepted.
The current cost-effectiveness seems acceptable (if the research group covers the publication fee), but I have the feeling that MDPI is becoming stricter this year. It is important to have a strong narrative, as submitting a paper that seems too superficial might lead to rejection based on the template alone
(1) 讚! | shhfu9jdh

作者: shhfu9jdh


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-12-21 22:29:56 評論於
2023-07-03 Submitted
2023-07-04 under review
2023-08-01 major revision (two reviewers)
2023-08-05 Revision R1
2023-08-06 under review
2023-08-07 Accept (reviewers are satisfied)
2023-08-08 Proofreading
2023-08-10 Online 
Journal suitable for interdisciplinary work in medical engineering, fast review, high efficiency, OA journal
(0) 讚! | shhfu9jdh

作者: Laban


領域: 工程技术
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-12-20 13:38:05 評論於
Journal editors are very responsible and respond quickly to any issues raised. They find professional reviewers who provide insightful feedback, and after making revisions based on their comments, the quality of the manuscript significantly improves. If the quality of the manuscript is poor, it will be rejected
(1) 讚! | Laban

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Bioengineering-Basel] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*